We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Electroencephalography (EEG) and Deep Brain Stimulation (DBS) in Epilepsy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00194870
First Posted: September 19, 2005
Last Update Posted: January 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Douglas R. Labar, Weill Medical College of Cornell University
  Purpose
Patients with epilepsy undergoing deep brain stimulation (DBS) have electroencephalograms (EEGs) recorded before and during their stimulation treatment. Subsequently the investigators will be using computer-assisted analysis of the digitally-recorded EEG signals to assess the effects of DBS on the brain-wave frequency content and any abnormal seizure-like patterns that may be present.

Condition Intervention
Epilepsy Procedure: computer-assisted analysis of the digitally-recorded EEG signals

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Diagnostic
Official Title: Electroencephalography (EEG) and Deep Brain Stimulation (DBS) in Epilepsy

Resource links provided by NLM:


Further study details as provided by Douglas R. Labar, Weill Medical College of Cornell University:

Primary Outcome Measures:
  • NA- observational study [ Time Frame: 5 years appr. ]

Enrollment: 5
Study Start Date: October 2003
Study Completion Date: December 2010
Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Digital EEG
Digital EEG
Procedure: computer-assisted analysis of the digitally-recorded EEG signals
computer-assisted analysis of the digitally-recorded EEG signals

  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • To be scheduled to undergo deep brain stimulation therapy (DBS) in an attempt to treat intractable epilepsy

Exclusion Criteria:

  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00194870


Locations
United States, New York
Weill Medical College at Cornell University - Comprehensive Epilepsy Center
New York, New York, United States, 10021
Weill Cornell Medical College
New York, New York, United States, 10065
Sponsors and Collaborators
Douglas R. Labar
Investigators
Principal Investigator: Douglas R Labar, MD, PhD Weill Medical College at Cornell University
  More Information

Responsible Party: Douglas R. Labar, Director of Clinical neurophysiology, Weill Medical College of Cornell University
ClinicalTrials.gov Identifier: NCT00194870     History of Changes
Other Study ID Numbers: 0309006367
First Submitted: September 12, 2005
First Posted: September 19, 2005
Last Update Posted: January 12, 2017
Last Verified: January 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Keywords provided by Douglas R. Labar, Weill Medical College of Cornell University:
EEG
DBS

Additional relevant MeSH terms:
Epilepsy
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases